CHEBI:35679 - antilipemic drug

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name antilipemic drug
ChEBI ID CHEBI:35679
Definition A substance used to treat hyperlipidemia (an excess of lipids in the blood).
Stars This entity has been manually annotated by the ChEBI Team.
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
ChEBI Ontology
Outgoing antilipemic drug (CHEBI:35679) is a drug (CHEBI:23888)
Incoming (+)-schisandrin B (CHEBI:132471) has role antilipemic drug (CHEBI:35679)
(R)-carnitine (CHEBI:16347) has role antilipemic drug (CHEBI:35679)
3-pyridinemethanol (CHEBI:45213) has role antilipemic drug (CHEBI:35679)
4,5,4'-trihydroxy-3,3'-dimethoxybibenzyl (CHEBI:193138) has role antilipemic drug (CHEBI:35679)
trans-rhaponticin (CHEBI:8824) has role antilipemic drug (CHEBI:35679)
D-psicose (CHEBI:27605) has role antilipemic drug (CHEBI:35679)
akebia saponin D (CHEBI:194124) has role antilipemic drug (CHEBI:35679)
ascofuranone (CHEBI:156148) has role antilipemic drug (CHEBI:35679)
bempedoic acid (CHEBI:149601) has role antilipemic drug (CHEBI:35679)
berberine (CHEBI:16118) has role antilipemic drug (CHEBI:35679)
bezafibrate (CHEBI:47612) has role antilipemic drug (CHEBI:35679)
cerulenin (CHEBI:171741) has role antilipemic drug (CHEBI:35679)
ciprofibrate (CHEBI:50867) has role antilipemic drug (CHEBI:35679)
clofibrate (CHEBI:3750) has role antilipemic drug (CHEBI:35679)
clofibric acid (CHEBI:34648) has role antilipemic drug (CHEBI:35679)
compactin diol lactone (CHEBI:34652) has role antilipemic drug (CHEBI:35679)
diallyl trisulfide (CHEBI:78492) has role antilipemic drug (CHEBI:35679)
ethionamide (CHEBI:4885) has role antilipemic drug (CHEBI:35679)
ethionamide S-oxide (CHEBI:87805) has role antilipemic drug (CHEBI:35679)
ezetimibe (CHEBI:49040) has role antilipemic drug (CHEBI:35679)
fenofibrate (CHEBI:5001) has role antilipemic drug (CHEBI:35679)
fluvastatin sodium (CHEBI:5137) has role antilipemic drug (CHEBI:35679)
FR177391 (CHEBI:65911) has role antilipemic drug (CHEBI:35679)
fucoidan (CHEBI:5181) has role antilipemic drug (CHEBI:35679)
gemfibrozil (CHEBI:5296) has role antilipemic drug (CHEBI:35679)
herbacetin (CHEBI:27673) has role antilipemic drug (CHEBI:35679)
loteprednol (CHEBI:50848) has role antilipemic drug (CHEBI:35679)
marsupsin (CHEBI:66680) has role antilipemic drug (CHEBI:35679)
MEDICA 16 (CHEBI:149582) has role antilipemic drug (CHEBI:35679)
ML-236C (CHEBI:34828) has role antilipemic drug (CHEBI:35679)
monascin (CHEBI:82621) has role antilipemic drug (CHEBI:35679)
nafenopin (CHEBI:7449) has role antilipemic drug (CHEBI:35679)
naringenin 7-O-β-D-glucoside (CHEBI:28327) has role antilipemic drug (CHEBI:35679)
nicotinic acid (CHEBI:15940) has role antilipemic drug (CHEBI:35679)
pemafibrate (CHEBI:228365) has role antilipemic drug (CHEBI:35679)
perfluorooctane-1-sulfonic acid (CHEBI:39421) has role antilipemic drug (CHEBI:35679)
PF-06446846 (CHEBI:189659) has role antilipemic drug (CHEBI:35679)
probucol (CHEBI:8427) has role antilipemic drug (CHEBI:35679)
rosuvastatin (CHEBI:38545) has role antilipemic drug (CHEBI:35679)
salvigenin (CHEBI:192703) has role antilipemic drug (CHEBI:35679)
scoparone (CHEBI:9055) has role antilipemic drug (CHEBI:35679)
UAB126 (CHEBI:176496) has role antilipemic drug (CHEBI:35679)
anticholesteremic drug (CHEBI:35821) is a antilipemic drug (CHEBI:35679)
Synonyms Sources
antihyperlipemic ChEBI
antihyperlipemics ChEBI
antihyperlipidaemic agent ChEBI
antihyperlipidaemic agents ChEBI
antihyperlipidaemic drug ChEBI
antihyperlipidaemic drugs ChEBI
antihyperlipidemic ChEBI
antihyperlipidemic agent ChEBI
antihyperlipidemic agents ChEBI
antihyperlipidemic drug ChEBI
antihyperlipidemic drugs ChEBI
antihyperlipidemics ChEBI
antilipemic ChEBI
antilipemic drugs ChEBI
antilipemics ChEBI
hypolipidemic agent ChEBI
hypolipidemic agents ChEBI
lipid-lowering agent ChEBI
lipid-lowering agents ChEBI
lipid-lowering drug ChEBI
lipid-lowering drugs ChEBI
Manual Xref Database
Hypolipidemic_agent Wikipedia
View more database links
Last Modified
03 January 2024